Skip to main content
Implanet SA logo

Implanet SA — Investor Relations & Filings

Ticker · ALIMP ISIN · FR0013470168 LEI · 969500CIMHFWNM4J4V14 PA Manufacturing
Open in API
Filings indexed 266 across all filing types
Latest filing 2026-04-20 Declaration of Voting R…
Country FR France
Listing PA ALIMP

About Implanet SA

http://www.implanet.com/en

Implanet is a medical technology company that designs, manufactures, and markets a range of implants and instruments for orthopedic surgery, with a specialized focus on spinal applications. The company's core offering is centered around its flagship Jazz™ platform, a latest-generation hybrid posterior fixation system intended to improve the treatment of various spinal disorders, including scoliosis. The product portfolio also includes other spinal systems such as Zeus™ and Saxxo™, Swingo™ interbody cages, Origin™ anterior cervical plates, and the Olea™ system for ultrasonic osteotomy. Additionally, Implanet provides complementary solutions like Neobone™ bone grafts. The company's products are utilized by surgeons and healthcare professionals in the field of spinal surgery.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release summarizing the outcome of Implanet’s Assemblée Générale Mixte held on 17 April 2026, including quorum details and adoption of resolutions (e.g., renewal of director mandates). It provides official voting results rather than the full AGM materials or a financial report. This fits the Definition for Declaration of Voting Results (Code: DVA).
2026-04-20 French
Informations privilégiées / Autres communiqués
Earnings Release Classification · 1% confidence The document is a press release dated April 14, 2026, summarizing Implanet’s first‐quarter 2026 revenue, highlighting key figures, year‐on‐year growth percentages, regional breakdowns, cash position, management commentary, and guidance for the next earnings release. It is not a full interim financial report (with complete financial statements) but rather the initial announcement of quarterly financial results. This aligns with the definition of an Earnings Release (ER). Q1 2026
2026-04-14 French
Inside Information / Other news releases
Earnings Release Classification · 1% confidence The document is a press release announcing IMPLANET’s first-quarter 2026 revenue figures, with key highlights, percentage changes year-over-year, regional breakdown, cash position, strategy and outlook, and next release date. It is not a full interim report but an initial quarterly financial announcement. These characteristics match an Earnings Release. Q1 2026
2026-04-14 English
Modalités de mise à disposition de document de référence ou de ses actualisations
Report Publication Announcement Classification · 1% confidence The document is a press release (‘Communiqué de presse’) announcing that IMPLANET’s annual financial report for 2025 has been published and is available via links. It does not contain the report itself, but merely provides publication details and a link to download it. Under the “menu vs meal” rule, this is a Report Publication Announcement (RPA).
2026-03-27 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is a press release announcing that Implanet has received FDA clearance for its Swingo™ 3D cage range. It describes a specific corporate development (product regulatory approval) rather than a financial report, shareholder meeting, or governance change. Since it does not fit into the specific categories for financial results, M&A, or share transactions, it falls under the general regulatory/corporate announcement category.
2026-03-03 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is a press release from Implanet announcing that they have received FDA approval for their new 3D-printed cervical cage product line (Swingo). It describes the product, its strategic importance for the US market, and provides contact information. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general corporate regulatory/news announcement, it falls under the RNS (Regulatory Filings) category.
2026-03-03 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.